🎥 Miss the @eurordis.bsky.social #Webinar on the 🇪🇺 #EU List of #CriticalMedicines? The recording is now available! #EHC CEO Olivia Romero Lux & Public Policy Lead Roberta Sadauskaite were among the speakers. 👇 ▶️ www.eurordis.org/webinar-unio...
#RareDisease
#EANM submitted its response to the European Medicines Agency (EMA) consultation on the Union List of #CriticalMedicines, advocating for the inclusion of six #radiopharmaceuticals that play an irreplaceable role in the diagnosis and treatment of cancer and other diseases.
🔗 https://bit.ly/3PurUqd
🗣️ Next week, EHC CEO Olivia Romero Lux & Public Policy Lead Roberta Sadauskaite will join this interactive discussion on the European Union's List of #CriticalMedicines & what it means for #RareDisease communities like ours. Don't miss it, register now!👇
📣 It’s time for @ema.europa.eu to add #VonWillebrandFactor (VWF) to the EU #CriticalMedicines List! VWF is life-saving for patients with #VonWillebrandDisease, the most common inherited bleeding disorder. Read our full statement here 🔗
buff.ly/3egmFbB
Keith Ridge, former chief pharmaceutical officer for England, has raised concerns that there is no explicit government policy around the stockpiling of critical medicines
#ukpharmacy #medicinesshortages #criticalmedicines
🩸 Today is #WorldPatientSafetyDay! 🩸 #PatientSafety means ensuring no one is left without #CriticalMedicines. 📣 EHC calls for #VonWillebrandFactor to be added to the EU List of Critical Medicines. 🇪🇺 Read more: buff.ly/PZwEYnH
#WPSD2025
📣 It’s time for @ema.europa.eu to add #VonWillebrandFactor (VWF) to the EU #CriticalMedicines List! VWF is life-saving for patients with #VonWillebrandDisease, the most common inherited bleeding disorder. Read our full statement 🔗 buff.ly/PZwEYnH
Speakers agreed that the #CriticalMedicines Act should place equal emphasis on:
🔴 Incentives for #EU-based manufacturing
🔴 Collaborative procurement across the EU
🔴 International #partnerships for sourcing of critical medicines
Full #event recording 👇
epc.eu/en/past-even...
Work has started at CCMI on the #CriticalMedicines Act 💊
Discussing improving access to medicines, boosting local production within the EU and strengthening supply chain security for a resilient and reliable pharmaceutical industry💪🇪🇺
More info ➡️europa.eu/!WvxHN6
@ec.europa.eu
Mid 2025 to do the first vulnerability assessment of #CriticalMedicines is very ambitious says Theo Guillaumont, co-chair of the WG1 of the #CMA. If it is done by the end of 2025 we will be happy. #HealthUnion
@ec.europa.eu has launched a call for evidence in the upcoming #CriticalMedicines Act 💉💊. Until 27/02 say your expertise/opinion on how to guarantee wide access and availability of medicines, ensuring every EU citizen right to health is fully fulfilled. #HERA
⏩ ec.europa.eu/info/law/bet...